| Consensus guidelines for the detection of immunogenic cell death O Kepp, L Senovilla, I Vitale, E Vacchelli, S Adjemian, P Agostinis, ... Oncoimmunology 3 (9), e955691, 2014 | 877 | 2014 |
| Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228 X Yu, ZS Guo, MG Marcu, L Neckers, DM Nguyen, GA Chen, DS Schrump Journal of the National Cancer Institute 94 (7), 504-513, 2002 | 487 | 2002 |
| Oncolytic viruses as therapeutic cancer vaccines DL Bartlett, Z Liu, M Sathaiah, R Ravindranathan, Z Guo, Y He, ZS Guo Molecular cancer 12, 1-16, 2013 | 383 | 2013 |
| Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy Z Liu, R Ravindranathan, P Kalinski, ZS Guo, DL Bartlett Nature communications 8 (1), 14754, 2017 | 348 | 2017 |
| Oncolytic immunotherapy: dying the right way is a key to eliciting potent antitumor immunity ZS Guo, Z Liu, DL Bartlett Frontiers in oncology 4, 74, 2014 | 309 | 2014 |
| Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics ZS Guo, B Lu, Z Guo, E Giehl, M Feist, E Dai, W Liu, WJ Storkus, Y He, ... Journal for immunotherapy of cancer 7, 1-21, 2019 | 288 | 2019 |
| Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses ZS Guo, SH Thorne, DL Bartlett Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1785 (2), 217-231, 2008 | 269 | 2008 |
| The neuronal repressor REST/NRSF is an essential regulator in medulloblastoma cells P Lawinger, R Venugopal, ZS Guo, A Immaneni, D Sengupta, W Lu, ... Nature medicine 6 (7), 826-831, 2000 | 223 | 2000 |
| Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer. ZS Guo, LH Wang, RC Eisensmith, SL Woo Gene therapy 3 (9), 802-810, 1996 | 217 | 1996 |
| Sequential 5-aza-2′-deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes … TS Weiser, ZS Guo, GA Ohnmacht, ML Parkhurst, P Tong-On, ... Journal of Immunotherapy 24 (2), 151-161, 2001 | 212 | 2001 |
| Imaging Adenoviral-mediated Herpes Virus Thymidine Kinase Gene Transfer and Expression In Vivo JG Tjuvajev, S Hsia Chen, A Joshi, R Joshi, Z Sheng Guo, J Balatoni, ... Cancer research 59 (20), 5186-5193, 1999 | 207 | 1999 |
| T-cell engager-armed oncolytic vaccinia virus significantly enhances antitumor therapy F Yu, X Wang, ZS Guo, DL Bartlett, SM Gottschalk, XT Song Molecular Therapy 22 (1), 102-111, 2014 | 205 | 2014 |
| Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway YH Kim, DH Lee, JH Jeong, ZS Guo, YJ Lee Biochemical pharmacology 75 (10), 1946-1958, 2008 | 195 | 2008 |
| First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activity HJ Zeh, S Downs-Canner, JA McCart, ZS Guo, UNM Rao, L Ramalingam, ... Molecular Therapy 23 (1), 202-214, 2015 | 188 | 2015 |
| Tumor-specific transcriptional targeting of suicide gene therapy J Qiao, M Doubrovin, BV Sauter, Y Huang, ZS Guo, J Balatoni, T Akhurst, ... Gene therapy 9 (3), 168-175, 2002 | 176 | 2002 |
| Epigenetic modulation of antitumor immunity for improved cancer immunotherapy E Dai, Z Zhu, S Wahed, Z Qu, WJ Storkus, ZS Guo Molecular cancer 20, 1-27, 2021 | 175 | 2021 |
| The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2 ZS Guo, A Naik, ME O'Malley, P Popovic, R Demarco, Y Hu, X Yin, S Yang, ... Cancer research 65 (21), 9991-9998, 2005 | 169 | 2005 |
| De novo induction of a cancer/testis antigen by 5-aza-2′-deoxycytidine augments adoptive immunotherapy in a murine tumor model ZS Guo, JA Hong, KR Irvine, GA Chen, PJ Spiess, Y Liu, G Zeng, ... Cancer research 66 (2), 1105-1113, 2006 | 166 | 2006 |
| Chemokine expression from oncolytic vaccinia virus enhances vaccine therapies of cancer J Li, M O'malley, J Urban, P Sampath, ZS Guo, P Kalinski, SH Thorne, ... Molecular Therapy 19 (4), 650-657, 2011 | 153 | 2011 |
| Phase 1 study of intravenous oncolytic poxvirus (vvDD) in patients with advanced solid cancers S Downs-Canner, ZS Guo, R Ravindranathan, CJ Breitbach, ME O'malley, ... Molecular Therapy 24 (8), 1492-1501, 2016 | 152 | 2016 |
herbert zehUT SouthwesternPotvrđena adresa e-pošte na utsouthwestern.edu
